37
Patent Applications Overlapping the Biotechnology and Mechanical Arts THOMAS BARRETT THOMAS BARRETT TC3700TQAS TC3700TQAS [email protected] [email protected]

Patent Applications Overlapping the Biotechnology and Mechanical Arts THOMAS BARRETT [email protected]

  • View
    216

  • Download
    0

Embed Size (px)

Citation preview

Patent Applications Overlapping the Biotechnology and Mechanical Arts

THOMAS BARRETTTHOMAS BARRETT

TC3700TQASTC3700TQAS

[email protected]@uspto.gov

2

OverviewOverview

The overlap of patent applications within the The overlap of patent applications within the biotechnology and mechanical artsbiotechnology and mechanical arts

How patent applications are classifiedHow patent applications are classified

101 and claims directed towards a 101 and claims directed towards a combination that includes parts of the combination that includes parts of the human bodyhuman body

3

Intersection of Biotechnology and Mechanical Arts

An example of a biotechnology class associated with the mechanical arts is Class 435-Chemistry: Molecular Biology and Microbiology

An example of a mechanical class associated with biotechnology arts is Class 623- Prosthesis (i.e., Artificial Body Members), Parts Thereof, or Aids and Accessories Therefor

4

Class 435Class 435

Over 172,000 patents & published applications

Within these 172,000 references, over 8,000 disclose at least one of the following delivery devices:

Stent, prosthetic or prosthesis.

5

Class 623Class 623

Nearly 30,000 patents & published applications, including stents, prosthetics and prostheses.

6

Areas of Overlapping ArtAreas of Overlapping Art

Stents and prosthetics are just some of the possible devices found in the mechanical art that can be used for delivery of body treating compositions.

Other delivery devices, such as syringes, are less often claimed in combination with the treating compositions.

7

ExampleExample

Coatings for eluting therapeutic Coatings for eluting therapeutic compositions on stents. These therapeutic compositions on stents. These therapeutic compositions may act as anti-thrombotics, compositions may act as anti-thrombotics, antibiotics, and anti-inflammatories etc.antibiotics, and anti-inflammatories etc.

8

ObviousnessObviousness

If a body treating therapeutic composition is If a body treating therapeutic composition is disclosed within the prior art as acting as disclosed within the prior art as acting as anti-thrombotics, antibiotics, and anti-anti-thrombotics, antibiotics, and anti-inflammatories etc., and the stent is not inflammatories etc., and the stent is not novel, the combination of the composition novel, the combination of the composition and the stent may be obvious.and the stent may be obvious.

9

Example ClaimExample Claim

A vascular stent graft comprising:a biologically active surface which exhibits cell

attachment activity and growth activity,said surface having linked thereto the expressed

protein of a vector containing a DNA sequence of cDNA coding for the A chain of laminin.

10

Some Rationales for ObviousnessSome Rationales for Obviousness

Simple substitution of one known element Simple substitution of one known element for another to obtain predictable resultsfor another to obtain predictable results

Combination of familiar elements according Combination of familiar elements according to known methods is likely to be obvious to known methods is likely to be obvious when it does no more than yield predictable when it does no more than yield predictable results. results.

11

Possible Rebuttal EvidencePossible Rebuttal Evidence

One of ordinary skill in the art could not have One of ordinary skill in the art could not have combined the claimed elements by known methods combined the claimed elements by known methods (e.g., due to technological difficulties);(e.g., due to technological difficulties);

The elements in combination do not merely The elements in combination do not merely perform the function that each element performs perform the function that each element performs separately; orseparately; or

The results of the claimed combination were The results of the claimed combination were unexpected.unexpected.

12

Where is the Application Where is the Application Classified?Classified?

If the claims are directed to both a body If the claims are directed to both a body treating composition and a mechanical treating composition and a mechanical device, what class is it placed in?device, what class is it placed in?

13

Purposes of ClassificationPurposes of Classification

For administrative and examination For administrative and examination purposes (e.g., ensuring the examination of purposes (e.g., ensuring the examination of patent applications by the best qualified patent applications by the best qualified examiner on the subject matter, restricting examiner on the subject matter, restricting patent applications to properly related patent applications to properly related inventions, interference or infringement inventions, interference or infringement searches, etc.), there is a need to designate searches, etc.), there is a need to designate for U.S. patents a primary, or Original, for U.S. patents a primary, or Original, classification. classification.

14

Purposes of Classification (cont)Purposes of Classification (cont)

Applications placed in the correct class, Applications placed in the correct class, subclass and technology center from the subclass and technology center from the start can also help reduce pendency.start can also help reduce pendency.

15

ClassificationClassification

In this section we will look at:In this section we will look at:

How an application is classified.How an application is classified.

How an applicant can help to ensure proper How an applicant can help to ensure proper classification.classification.

16

Classifying Patent Applications Classifying Patent Applications and PGPubs: Controlling Claimand PGPubs: Controlling Claim

If a document has claims directed towardsIf a document has claims directed towards inventions classified separately, the inventions classified separately, the controlling claim:controlling claim:

a) Determines the class for the original a) Determines the class for the original classification and,classification and,

b) Determines the class where a patent b) Determines the class where a patent application is to be assigned for examinationapplication is to be assigned for examination

17

Classifying Patents and PGPubs: Classifying Patents and PGPubs: Controlling ClaimsControlling Claims

Principles used to determine the Principles used to determine the controlling claim (in order of precedence):controlling claim (in order of precedence):

I.I. Most Comprehensive ClaimMost Comprehensive Claim

II.II. Hierarchy of Categories of Subject MatterHierarchy of Categories of Subject Matter

III.III. Superiority of types of subject matterSuperiority of types of subject matter

IV.IV. Class SuperiorityClass Superiority

18

Most Comprehensive ClaimMost Comprehensive Claim

The claim setting forth the most The claim setting forth the most comprehensive organization (for example, a comprehensive organization (for example, a claim to a combination as compared to a claim to a combination as compared to a claim to a subcombination or element of that claim to a subcombination or element of that combination) will control placement of a combination) will control placement of a patent or application among classes.patent or application among classes.

19

ExampleExample

1. A coating for a vascular graft having a polymeric external surface comprising: a biologically active surface which exhibits cell attachment activity and growth activity, said surface having linked thereto the expressed protein of a vector. 2. The coating of claim 1, wherein said vector contains a DNA sequence of cDNA coding for the A chain of laminin.

3. The coating of claim 1, in combination with a vascular graft.

20

Exception - Most “Examinable”Exception - Most “Examinable”

In cases where there is a claim drawn to In cases where there is a claim drawn to hybrid or mixed subject matter and the hybrid or mixed subject matter and the Supervisor in one discipline determines that Supervisor in one discipline determines that the application requires consideration by, or the application requires consideration by, or may be best examined by, a TC in one of the may be best examined by, a TC in one of the other technical disciplines, he or she may other technical disciplines, he or she may request a transfer of the application on a request a transfer of the application on a "best examinable" basis."best examinable" basis.

21

Reasons Supporting a Transfer of Reasons Supporting a Transfer of an Applicationan Application

An application contains a hybrid claim wherein, for An application contains a hybrid claim wherein, for instance, a product is defined merely in terms of instance, a product is defined merely in terms of the process for producing it. the process for producing it.

Where an application properly assigned to a Where an application properly assigned to a mechanical class contains at least one claim to mechanical class contains at least one claim to mixed subject matter, a part of which is mixed subject matter, a part of which is biotechnical, the application biotechnical, the application maymay be assigned to be assigned to the appropriate biotechnology art unit for the appropriate biotechnology art unit for examination.examination.

22

Application Data Sheet

Application information in the Application Data Sheet- This information includes a This information includes a suggested classification, by class and suggested classification, by class and subclass and the Technology Center to subclass and the Technology Center to which the subject matter of the invention is which the subject matter of the invention is assigned. assigned.

23

PCTsPCTs

If a U.S. national application has been acted If a U.S. national application has been acted upon by an examiner to whom the national upon by an examiner to whom the national application was assigned on the basis of the application was assigned on the basis of the controlling (not necessarily the first) claim, a controlling (not necessarily the first) claim, a subsequent PCT application claiming subsequent PCT application claiming priority of the national application will priority of the national application will normally be assigned to the same examiner, normally be assigned to the same examiner, or to the examiner's art unit in his/her or to the examiner's art unit in his/her absence.absence.

24

PCTs PCTs

In all other situations where a U.S. national application and a corresponding PCT application are copending, irrespective of which application was filed first, every effort should be made to ensure that both applications are assigned for search and examination to the examiner to whom the PCT application would normally be assigned on the basis of the first claimed invention, or to the examiner's art unit in his/her absence.

25

Information Resources for Information Resources for ClassificationClassification

MPEP 902-903.09(a)MPEP 902-903.09(a)

Examiner Handbook to the U.S. Patent Examiner Handbook to the U.S. Patent Classification System –Classification System –

Available online at: Available online at: www.uspto.gov/web/offices/pac/dapp/sir/co/examhbk/index.htmwww.uspto.gov/web/offices/pac/dapp/sir/co/examhbk/index.htm

26

Within the overlap of biotechnology and mechanical arts, an issue sometimes occurs wherein a claim recites an apparatus (as opposed to a method) with certain elements “attached to” the human body or specific body parts.

Combinations Including Parts of the Human Body

27

Functional Recitations

Limitations to parts of the human body presents no problem as long as the language is recited in the format “adapted to be attached” or “for attachment to” or in some similar way which does not positively set forth the human body or portions thereof as part of the claimed subject matter.

28

Claimed Combination

But what about those situations where the portion of the human body is actually set forth as part of the claimed combination?

29

MPEP 2105- Patentable Subject Matter

If the broadest reasonable interpretation of the claimed invention as a whole encompasses a human being, then a rejection under 35 USC 101 must be made indicating that the claimed invention is directed to nonstatutory subject matter.

30

On April 7, 1987, then Assistant Secretary and Commissioner of Patents and Trademarks,

Donald J. Quigg, set forth PTO policy on this issue in the form of a notice entitled “Animals – Patentability”.

Animals-Patentability Animals-Patentability

31

Animals-PatentabilityAnimals-Patentability

The notice stated that the “Patent and Trademark Office would now consider nonnaturally occurring non-human multicellular living organisms, including animals, to be patentable subject matter within the scope of 35 U.S.C. 101”

32

Animals-PatentabilityAnimals-Patentability

The Commissioner stated that a “claim directed to or including within its scope a human being will not be considered to be patentable subject matter under 35 U.S.C. 101” since the grant of a limited, but exclusive property right in a human being is prohibited by the Constitution.

33

Claimed Combination

Accordingly, where a claim is directed to apparatus “attached to” the human body or any part thereof an examiner is to reject such claim under 35 U.S.C. 101.

34

112 1st Paragraph

However, claims which contain language “attached to” a part of the human body raise an issue under 35 U.S.C. 101 but do not inherently raise questions of enablement or indefiniteness.

35

ExampleExample

An intravascular stent which is permanently implanted in the vessel lumen of a patient and which is used for locally delivering genes in a vessel comprising: (a) a substrate, (b) a coating adhering to the substrate, and (c) a genetic material which is adsorbed to the surface of the coating, wherein the coating comprises a matrix of randomly interconnected protein molecules comprising one or more species of protein.

36

ExampleExample

An intravascular stent FOR permanent implantation in the vessel lumen of a patient and which is used for locally delivering genes in a vessel comprising: (a) a substrate, (b) a coating adhering to the substrate, and (c) a genetic material which is adsorbed to the surface of the coating, wherein the coating comprises a matrix of randomly interconnected protein molecules comprising one or more species of protein.

37

Questions?Questions?

THOMAS BARRETTTHOMAS BARRETTTC3700TQASTC3700TQAS

[email protected]@uspto.gov